Avanos Medical (AVNS) Shareholder's Equity (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.50% |
| Dec 31, 2025 | 0.03% |
| Sep 30, 2025 | 2,531.25% |
| Jun 30, 2025 | -103.81% |
| Mar 31, 2025 | 947.88% |
| Dec 31, 2024 | -108.05% |
| Sep 30, 2024 | 491.62% |
| Jun 30, 2024 | 0.57% |
| Mar 31, 2024 | -125.54% |
| Dec 31, 2023 | 1.16% |
| Sep 30, 2023 | 1,833.48% |
| Jun 30, 2023 | -125.24% |
| Mar 31, 2023 | -102.42% |
| Dec 31, 2022 | 2.19% |
| Sep 30, 2022 | -22.83% |
| Jun 30, 2022 | 0.25% |
| Mar 31, 2022 | 28.55% |
| Dec 31, 2021 | 0.28% |
| Sep 30, 2021 | -2.66% |
| Jun 30, 2021 | 3.52% |
| Mar 31, 2021 | -0.37% |
| Dec 31, 2020 | -2.16% |
| Sep 30, 2020 | 14,120.65% |
| Jun 30, 2020 | 80.38% |
| Mar 31, 2020 | -103.69% |
| Dec 31, 2019 | 0.45% |
| Sep 30, 2019 | 14,831.40% |
| Jun 30, 2019 | 96.73% |
| Mar 31, 2019 | -120.25% |
| Dec 31, 2018 | -0.23% |
| Sep 30, 2018 | -17.06% |
| Jun 30, 2018 | 0.67% |
| Mar 31, 2018 | 28.13% |
| Dec 31, 2017 | 2.94% |
| Sep 30, 2017 | 2.07% |
| Jun 30, 2017 | 2.29% |
| Mar 31, 2017 | 2.58% |
| Dec 31, 2016 | 0.09% |
| Sep 30, 2016 | 1.10% |
| Jun 30, 2016 | 0.90% |
| Mar 31, 2016 | 2.32% |
| Dec 31, 2015 | 1.37% |
| Sep 30, 2015 | -31.59% |
| Jun 30, 2015 | 0.66% |
| Mar 31, 2015 | 1.38% |
| Dec 31, 2014 | -28.27% |
| Dec 31, 2013 | -1.54% |